<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Immune reconstitution after allogeneic stem cell transplantation protects against <z:e sem="disease" ids="C0029118" disease_type="Disease or Syndrome" abbrv="">opportunistic infections</z:e> and disease relapse </plain></SENT>
<SENT sid="1" pm="."><plain>Identifying the most protective lymphocyte subset would have implications of adoptive immunotherapy </plain></SENT>
<SENT sid="2" pm="."><plain>We followed up a case series of 34 allogeneic transplantations for pediatric <z:hpo ids='HP_0001909'>leukemias</z:hpo>, <z:hpo ids='HP_0001915'>aplastic anemias</z:hpo>, or <z:e sem="disease" ids="C0280100" disease_type="Neoplastic Process" abbrv="">solid tumors</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>Regardless of baseline <z:e sem="disease" ids="C1521860" disease_type="Disease or Syndrome" abbrv="">hematologic disorder</z:e>, the speed of reconstitution of cytotoxic CD8 T lymphocytes and the achieving of the 10th percentile of <z:mpath ids='MPATH_458'>normal</z:mpath> CD4 T lymphocytes (but not B lymphocytes or natural killer cells) conditioned overall survival </plain></SENT>
<SENT sid="4" pm="."><plain>The source of hematopoietic stem cells (peripheral blood vs bone marrow) and the occurrence of <z:e sem="disease" ids="C0018133" disease_type="Disease or Syndrome" abbrv="GVH">graft-versus-host disease</z:e> (either <z:hpo ids='HP_0011009'>acute</z:hpo> or <z:hpo ids='HP_0011010'>chronic</z:hpo>) did not impact on immune reconstitution </plain></SENT>
<SENT sid="5" pm="."><plain>Larger case series are needed to confirm the pivotal role of cytotoxic CD8 T lymphocytes in overall survival </plain></SENT>
</text></document>